CytoMed Therapeutics (GDTC) Price to Book (2023 - 2025)

CytoMed Therapeutics has disclosed Price to Book across 3 years of filings, most recently posting 3.0 for Q4 2025.

• In Q4 2025, Price to Book fell 48.06% year-over-year to 3.0; the TTM figure through Dec 2025 stood at 3.0 (down 48.06% YoY), while the FY2025 annual figure was 3.02, down 47.64% from the prior year.
• Price to Book came in at 3.0 for Q4 2025 at CytoMed Therapeutics, down from 3.6 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 6.79 in Q4 2023 to a low of 1.83 in Q2 2023.
• Average Price to Book over 3 years is 3.89, with a median of 3.3 recorded in 2025.
• The largest YoY upside for Price to Book was 52.19% in 2025 against a maximum downside of 48.06% in 2025.
• Over 3 years, Price to Book stood at 6.79 in 2023, then retreated by 15.0% to 5.77 in 2024, then slumped by 48.06% to 3.0 in 2025.
• Per Business Quant data, the three most recent Price to Book figures were 3.0 in Q4 2025, 3.6 in Q2 2025, and 5.77 in Q4 2024.